Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 337

1.

Predicting compliance of dual diagnosis inpatients with aftercare treatment.

Wolpe PR, Gorton G, Serota R, Sanford B.

Hosp Community Psychiatry. 1993 Jan;44(1):45-9.

PMID:
8382186
2.
3.

Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer?

Kranzler HR, Kadden RM, Burleson JA, Babor TF, Apter A, Rounsaville BJ.

Compr Psychiatry. 1995 Jul-Aug;36(4):278-88. Erratum in: Compr Psychiatry 1995 Sep-Oct;36(5):396.

PMID:
7554872
4.
5.

Addiction severity, psychopathology and treatment compliance in cocaine-dependent mothers.

Killeen TK, Brady KT, Thevos A.

J Addict Dis. 1995;14(1):75-84.

PMID:
7632749
6.

Comorbid substance abuse and recovery from acute psychiatric relapse.

Sanguineti VR, Samuel SE.

Hosp Community Psychiatry. 1993 Nov;44(11):1073-6.

PMID:
8288176
7.

Inpatient treatment for substance abuse patients with psychiatric disorders: a national study of determinants of readmission.

Swindle RW, Phibbs CS, Paradise MJ, Recine BP, Moos RH.

J Subst Abuse. 1995;7(1):79-97.

PMID:
7655313
8.

Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.

Clark RE, Xie H, Brunette MF.

J Clin Psychiatry. 2004 Feb;65(2):151-5.

PMID:
15003066
9.

Psychiatric and medical comorbidities of veterans with substance use disorders.

Walker RD, Howard MO, Lambert MD, Suchinsky R.

Hosp Community Psychiatry. 1994 Mar;45(3):232-7.

PMID:
8188193
10.

Psychiatric and social reasons for frequent rehospitalization.

Kent S, Yellowlees P.

Hosp Community Psychiatry. 1994 Apr;45(4):347-50.

PMID:
8020919
11.

Efficacy of group motivational interviewing (GMI) for psychiatric inpatients with chemical dependence.

Santa Ana EJ, Wulfert E, Nietert PJ.

J Consult Clin Psychol. 2007 Oct;75(5):816-22.

PMID:
17907864
12.

[Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].

Verdoux H, Mury M, Besançon G, Bourgeois M.

Encephale. 1996 Mar-Apr;22(2):95-101. French.

PMID:
8706627
13.

Three-month follow-up of 28 dual diagnosis inpatients.

Hoffman GW Jr, DiRito DC, McGill EC.

Am J Drug Alcohol Abuse. 1993;19(1):79-88.

PMID:
8438833
14.

Psychotherapy with dual diagnosis patients: working with denial.

Levy M.

J Subst Abuse Treat. 1993 Nov-Dec;10(6):499-504.

PMID:
8308933
15.

The effect of anxiety and depression on completion/withdrawal status in patients admitted to substance abuse detoxification program.

Araujo L, Goldberg P, Eyma J, Madhusoodanan S, Buff DD, Shamim K, Brenner R.

J Subst Abuse Treat. 1996 Jan-Feb;13(1):61-6.

PMID:
8699544
16.

Predictors of participation in aftercare sessions and self-help groups following completion of intensive outpatient treatment for substance abuse.

McKay JR, McLellan AT, Alterman AI, Cacciola JS, Rutherford MJ, O'Brien CP.

J Stud Alcohol. 1998 Mar;59(2):152-62.

PMID:
9500302
17.

A nationwide representative sample of treatment-seeking alcoholics: a study of psychiatric comorbidity.

Tómasson K, Vaglum P.

Acta Psychiatr Scand. 1995 Nov;92(5):378-85.

PMID:
8619343
18.

Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic.

Saxon AJ, Calsyn DA.

Am J Drug Alcohol Abuse. 1995 Aug;21(3):303-13.

PMID:
7484981
19.

Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.

Simmons LA, Havens JR.

J Affect Disord. 2007 Apr;99(1-3):265-71. Epub 2006 Sep 15.

PMID:
16978706
20.

Correlations between psychiatric disabilities and vocational outcome.

Jacobs HE, Wissusik D, Collier R, Stackman D, Burkeman D.

Hosp Community Psychiatry. 1992 Apr;43(4):365-9.

PMID:
1577428

Supplemental Content

Support Center